Early Regeneron tests indicate antibody drug could be less effective against Omicron
Early testing indicates that the mutations in the Omicron variant of coronavirus may hamper the ability of Regeneron’s antibody drug to treat Covid-19, the company said, suggesting that some therapies may have to be adapted to tackle the…